# Biogen Inc.: Form 8-K, filed Jan 14, 2026

- Company: [Biogen Inc.](/companies/biib.md) (CIK 875045)
- Form: 8-K
- Filed: 2026-01-14
- Accepted by EDGAR: Jan 13, 2026, 17:38 ET
- Period: 2026-01-13
- Accession: 0000875045-26-000003
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/875045/000087504526000003/biib-20260113.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/875045/000087504526000003/

## Items reported

- Item 2.02: Results of operations

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/875045/000087504526000003/biib-20260113.htm

Filed Jan 14, 2026.
Source: SEC EDGAR, the filing index for accession 0000875045-26-000003. Last ingested by Listed: Nov 2, 2026, 20:22 ET. No prices; not investment advice.